PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Metoclopramide hydrochloride - Nausea and vomiting (pregnancy)
PAD Profile : Metoclopramide hydrochloride - Nausea and vomiting (pregnancy) Important
Important Information :
2nd line treatment option. Should not be prescribed for longer than 5 days.
Traffic Light Status
Status 1 of 2.
Status :
Green (see narrative)
Formulations :
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Doxylamine succinate/pyridoxine hydrochloride
- Domperidone
- Cyclizine hydrochloride
- Promethazine teoclate
- Promethazine hydrochloride
- Prochlorperazine maleate
- Chlorpromazine hydrochloride
- Ondansetron hydrochloride
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC agreed a traffic light status and place in therapy for drugs used to treat nausea and vomiting in pregnancy.
Visit the Guideline Profile page for a full list of these drugs and to access the CKS guidelines for nasea & vomiting and pregnancy and the BUMPS website (Best Use of Medicines in Pregnancy).
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo